Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C).


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
02 Sep 2022
Historique:
entrez: 12 9 2022
pubmed: 13 9 2022
medline: 13 9 2022
Statut: epublish

Résumé

Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic inflammatory condition that follows SARS-CoV2 infection or exposure in children. Clinical presentations are highly variable and include fever, gastrointestinal (GI) disease, shock, and Kawasaki Disease-like illness (MIS-C/KD). Compared to patients with acute COVID, patients with MIS-C have a distinct immune signature and expansion of

Identifiants

pubmed: 36093351
doi: 10.1101/2022.08.31.22279265
pmc: PMC9460975
pii:
doi:

Types de publication

Preprint

Langues

eng

Commentaires et corrections

Type : UpdateIn

Références

Sci Rep. 2021 Jun 25;11(1):13308
pubmed: 34172783
Nat Commun. 2021 Dec 10;12(1):7222
pubmed: 34893640
Nat Med. 2022 May;28(5):1050-1062
pubmed: 35177862
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
J Clin Invest. 2021 May 17;131(10):
pubmed: 33705359
Lancet Child Adolesc Health. 2022 Jul;6(7):459-465
pubmed: 35526537
J Exp Med. 2022 Feb 7;219(2):
pubmed: 34914824

Auteurs

Christopher Redmond (C)

Vasculitis Translational Research Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health.

Moses M Kitakule (MM)

Columbia University Vagelos College of Physicians and Surgeons.

Aran Son (A)

Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

McKella Sylvester (M)

Vasculitis Translational Research Section, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health.

Keith Sacco (K)

Phoenix Children's Hospital.
University of Arizona.

Ottavia Delmonte (O)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Francesco Licciardi (F)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Riccardo Castagnoli (R)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Cecilia Poli (C)

Faculty of Medicine, Clinica Alemana Universidad del Desarrollo.
Division of Immunology and Rheumatology, Hospital Roberto del Rio.

Yasmin Espinoza (Y)

Division of Immunology and Rheumatology, Hospital Roberto del Rio.

Camila Astudillo (C)

Division of Immunology and Rheumatology, Hospital Roberto del Rio.

Sarah E Weber (SE)

Molecular Development of the Immune System Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Gina A Montealegre Sanchez (GAM)

Division of Clinical Medicine, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Karyl Barron (K)

Office of the Scientific Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Mary Magliocco (M)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Kerry Dobbs (K)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Yu Zhang (Y)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Helen Matthews (H)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Cihan Oguz (C)

Research Technologies Branch, Collaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Helen C Su (HC)

Human Immunological Diseases Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Luigi D Notarangelo (LD)

Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Pamela A Frischmeyer-Guerrerio (PA)

Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Daniella M Schwartz (DM)

Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
University of Pittsburgh, Division of Rheumatology and Clinical Immunology.

Classifications MeSH